Nanalysis Scientific (TSXV:NSCI) EBIT : C$-10.22 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific EBIT?

Nanalysis Scientific's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was C$-2.16 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-10.22 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nanalysis Scientific's annualized ROC % for the quarter that ended in Mar. 2024 was -14.61%. Nanalysis Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -70.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nanalysis Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -14.82%.

Nanalysis Scientific EBIT Historical Data

The historical data trend for Nanalysis Scientific's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific EBIT Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

0.06

-3.63

-1.19

-9.91

-13.51

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial															-5.03	-3.84	-6.12	1.90	-2.16

Competitive Comparison of Nanalysis Scientific's EBIT

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanalysis Scientific's EV-to-EBIT Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's EV-to-EBIT falls into.

Nanalysis Scientific EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-10.22 Mil.

Nanalysis Scientific (TSXV:NSCI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nanalysis Scientific's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-6.824 * ( 1 - -0.32% )	/	( (47.984	+	45.71)	/ 2 )
=	-6.8458368	/	46.847
=	-14.61 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.824	-	5.081	-	( 0.759	-	max(0, 14.596	-	17.914	+	0.759	))
=	47.984

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.979	-	6.575	-	( 1.694	-	max(0, 12.707	-	18.992	+	1.694	))
=	45.71

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Nanalysis Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-8.64	/	( ( (4.737 + max(8.413, 0))	+	(4.458 + max(6.766, 0)) )	/	2 )
=	-8.64	/	( ( 13.15	+	11.224 )	/	2 )
=	-8.64	/	12.187
=	-70.90 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.326	+	5.794	+	1.603)	-	(5.081	+	1.321	+	0.908)
=	8.413

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(9.241	+	4.827	+	1.804)	-	(6.575	+	1.612	+	0.919)
=	6.766

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nanalysis Scientific's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-10.215	/	68.917
	=	-14.82 %

Nanalysis Scientific EBIT Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines